|
|||||
|
|
Thalidomide: An option for the pediatric patient with actinic prurigo |
|
| Authors: | Anabella Watts-Santos MD Jessica Carolina Martinez-Rico MD Minerva Gomez-Flores MD DrSc Jorge Ocampo-Candiani MD DrSc Erika Alba-Rojas MD |
| Affiliation: | Dermatology Department, Universidad Autónoma de Nuevo León, Hospital Universitario “Dr. José Eleuterio González”, Monterrey, México |
| Abstract: | Actinic prurigo (AP) is an immune-mediated photodermatosis that usually starts in childhood and is predominant among American indigenous and mestizo communities. In adults with AP, thalidomide is the treatment of choice; however, there is little information on its use in pediatric patients. We report the case of a 10-year-old girl with AP treated successfully with thalidomide. |
| Keywords: | actinic prurigo photodermatosis photosensitivity thalidomide |